Juno Therapeutics Inc (NASDAQ:JUNO) shares gained 9% after the company said it will present updated clinical and preclinical results from the company and …
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) reported financial results for the three months ended September 30, 2017, and provided other general business updates. “We are …
Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced financial results for the three and nine months ended September 30, 2017, and provided an update on company …
INSY’s whopper of a lawsuit has Oppenheimer sounding off with a note of caution.
Rick Wise: High surgeon intrigue in TRXC’s Senhance; Mark Massaro: EXAS could hit 2.7M in tests by 2021.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced today that it will pay down $125 million of senior secured loans, keeping it on track with …
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced that the United States District Court for the District of Delaware has ruled in the Company’s favor in …
Maxim analyst Jason Kolbert is out today with a new research note on shares of ContraVir Pharmaceuticals Inc (NASDAQ:CTRV), following the company’s third-quarter results and …
Ed Arce lifts his price target on AUPH after recent R&D day widened doors to voclosporin’s opportunity.
Irina Rivkind Koffler worries that the Copaxone generics competitive backdrop threatens TEVA immensely.